The (new) top 10 pharma companies by 2017 revenue
Takeda CEO Christophe Weber will now be able to boast about his elevation into the top 10 global pharma companies, if you base the count on revenue.
I cobbled together the latest set of figures for fiscal 2017 to show you where the Takeda/Shire operation fits in to the big picture. I’ll note that while J&J is way out front, it’s a healthcare/pharma conglomerate with a wide range of products in its portfolio. And I backed out crop sciences revenue from Bayer to make this more about biopharma.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.